Kay Brickmann is a senior PhD business development and licensing professional with over 20 years of post-doctoral experience in the pharmaceutical industry. Currently, they serve as the Senior Director of Transactions, Business Development & Licensing at AstraZeneca and as the Director of the Board at OnDosis. Kay has a proven track record in negotiations and successful transactions across Europe, the USA, Japan, and China. They completed their PhD in Organic Chemistry at The University of Göttingen and have previously held postdoctoral positions at Lund University and the University of Umea. Fluent in German, English, and Swedish, Kay continues to contribute significantly to the development of innovative healthcare solutions.
This person is not in the org chart
This person is not in any teams
This person is not in any offices